Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma

被引：11
|
作者：
Uchiyama, Michihiro [1 ]
Tamai, Yotaro [1 ]
Ikeda, Takashi [1 ]
机构：
[1] Shizuoka Canc Ctr, Div Hematol & Stem Cell Transplantat, Nagaizumi, Shizuoka 4118777, Japan
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2010年 / 14卷 / 03期
关键词：
LAMIVUDINE THERAPY;
D O I：
10.1016/j.ijid.2009.04.014
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E265 / E266
页数：2
相关论文
共 50 条
  • [31] PROSPECTIVE STUDY OF HEPATITIS B VIRUS REACTIVATION IN HBSAG-NEGATIVE PATIENTS AFTER CHEMOTHERAPY WITH RITUXIMAB: HBV-DNA MONITORING AND ENTECAVIR PROPHYLAXIS
    Kojima, H.
    Tsujimura, H.
    Sugawara, T.
    Mimura, N.
    Ise, M.
    Sakai, C.
    Yamada, S.
    Miyaki, T.
    Kumagai, K.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S206 - S206
  • [32] PROSPECTIVE STUDY OF HEPATITIS B VIRUS REACTIVATION IN HBSAG-NEGATIVE PATIENTS AFTER CHEMOTHERAPY WITH RITUXIMAB: HBV-DNA MONITORING AND ENTECAVIR PROPHYLAXIS
    Kojima, H.
    Tsujimura, H.
    Mimura, N.
    Sugawara, T.
    Ise, M.
    Sakai, C.
    Yamada, S.
    Miyaki, T.
    Kumagai, K.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S292 - S292
  • [33] Treatment to Prevent Hepatitis B Virus Reactivation in Patients With Lymphoma Receiving Chemotherapy Reply
    Lin, Tongyu
    Huang, He
    Li, Xueying
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (12): : 1270 - 1270
  • [34] ENTECAVIR IS EFFECTIVE IN PREVENTING HEPATITIS B REACTIVATION IN CANCER PATIENTS RECEIVING CHEMOTHERAPY
    Mendelsohn, Robin B.
    Garett Ng
    Patel, Dhruv
    Taur, Ying
    Kamboj, Mini
    Zelenetz, Andrew D.
    Sepkowitz, Kent
    Ludwig, Emmy
    HEPATOLOGY, 2011, 54 : 883A - 883A
  • [35] Entecavir is Effective in Preventing Hepatitis B Reactivation in Cancer Patients Receiving Chemotherapy
    Mendelsohn, Robin B.
    Taur, Ying
    Ng, Garen
    Patel, Dhruv
    Kamboj, Mini
    Zelenetz, Andrew D.
    Sepkovritz, Kent
    Ludwig, Emmy
    GASTROENTEROLOGY, 2011, 140 (05) : S930 - S930
  • [36] Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: Role of lamivudine prophylaxis
    Coiffier, Bertrand
    CANCER INVESTIGATION, 2006, 24 (05) : 548 - 552
  • [37] Role of hepatitis B surface antigen in hepatitis B virus relapse after entecavir or tenofovir prophylaxis in patients undergoing cancer chemotherapy
    Kuo, Ming-Te
    Tseng, Po-Lin
    Chou, Yeh-Pin
    Chang, Kuo-Chin
    Tsai, Ming-Chao
    Kuo, Yuan-Hung
    Hu, Tsung-Hui
    Hung, Chao-Hung
    Wang, Jing-Houng
    Lu, Sheng-Nan
    Chen, Chien-Hung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (10) : 1766 - 1772
  • [38] Hepatitis B virus reactivation after cessation of prophylaxis with lamivudine in a patient with non-Hodgkin's lymphoma treated with chemotherapy and rituximab
    Vives, Susana
    Sancho, Juan Manuel
    Planas, Ramon
    Ribera, Josep Maria
    MEDICINA CLINICA, 2006, 127 (01): : 39 - 39
  • [39] Entecavir Is Safe and Effective As Prophylaxis for Reactivation of Hepatitis B Virus in Allogeneic Stem Cell Transplant Recipients with Chronic or Resolved Viral Hepatitis B Infection
    Tsuji, Masanori
    Ota, Hikari
    Nishida, Aya
    Ishiwata, Kazuya
    Yamamoto, Hisashi
    Yamamoto, Go
    Asano-Mori, Yuki
    Uchida, Naoyuki
    Izutsu, Koji
    Masuoka, Kazuhiro
    Wake, Atsushi
    Makino, Shigeyoshi
    Yoneyama, Akiko
    Taniguchi, Shuichi
    BLOOD, 2012, 120 (21)
  • [40] Evaluating Hepatitis B Virus Reactivation During Solid Tumor Chemotherapy: Evidence to Guide Pretreatment Hepatitis B Screening and Prophylaxis
    Lo Re, Vincent, III
    Schuster, Mindy
    ANNALS OF INTERNAL MEDICINE, 2016, 164 (01) : 64 - +
12345